Perspectives on Enquiry & Evidence

Cytel's blog featuring the latest industry insights.

Featured post

Aligning Clinical Trial Design with Investment Priorities

When working with investors, it’s critical that drug and device developers consider how their clinical trial design aligns with investment priorities. Natalia Muehlemann and Ari Brettman (Blackstone Life Sciences) discuss what investors look for when evaluating clinical development programs, and the value of simulation-guided design in informing decisions and facilitating communication with investors.

Read full article

Perspectives on Enquiry and Evidence

December 23, 2021

Year-End Roundup: Your Favorite Blog Posts of 2021

Cytel blogs bring you debate and discussion of the newest trends in statistics and quantitative strategy. In 2021, our...

Read article

May 12, 2021

Strategic Insights from Novel Bayesian Methods – Complimentary Paper

Did you know that Bayesian methods can strengthen Frequentist trials through the use of Bayesian decision criteria or...

Read article

February 1, 2021

February 2021: Updates from the CYTEL COVID-19 Trial Tracker

Cytel’s COVID-19 Trial Tracker continues to provide real time updates to the status of COVID-19 clinical trials...

Read article

January 11, 2021

COVID-19 Trial Tracker Updates (January 11)

In April 2020, Cytel launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater...

Read article

December 21, 2020

Year-End Roundup: Your Favorite Blog Posts of 2020

2020 has been an unusually difficult year as the global pandemic impacted all of our lives. This year, the Cytel blog...

Read article

August 11, 2020

Optimizing Information in Trial Design and Implementation

While there is increasing optimism about the discovery of a COVID-19 vaccine, one of the less talked about aspects of...

Read article

December 18, 2019

Year-End Roundup: Your Favorite Blog Posts of 2019

With only two weeks left for this fabulous year to end, we would like to thank all our blog subscribers and new readers...

Read article

January 30, 2019

Career Perspectives: Interview with Tina Checchio, Associate Director, Quantitative Pharmacology & Pharmacometrics

QPP remains at the heart of model based drug development. Short for Quantitative Pharmacology & Pharmacometrics, it...

Read article

January 10, 2019

Podcast: Overcoming Phase 1 Development Challenges

Nand Kishore Rawat is a Director and Head, Early Phase Biostatistics based in the King of Prussia, PA Cytel office. We...

Read article

December 5, 2018

Creating a Common Language: Forging Statistical and Clinical Collaborations

In this blog, Paul Terrill, Director of Strategic Consulting at Cytel outlines his blueprint for ensuring smooth...

Read article

November 27, 2018

The Good Data Submission Doctor: 5 Top ADaM Frequently Asked Questions

This is the third in our blog series ' The Good Data Submission Doctor' in which Angelo Tinazzi, Director of Standards,...

Read article

November 5, 2018

New publication addresses critical issues in ultra-orphan indications

Cytel biostatisticians Cyrus Mehta and Lingyun Liu, together with Charles Theuer, CEO of TRACON Pharmaceuticals have...

Read article

November 1, 2018

The Good Data Submission Doctor: 5 Top SDTM Frequently Asked Questions

In this second post of the “Good Data Submission Doctor” ( read my first post The Master Recipe: Quality and Attention...

Read article

October 26, 2018

Patient preferences into risk-benefit calculations opens new horizons

Read article

October 23, 2018

Career Perspectives: Interview with Munshi Imran Hossain, Senior Data Scientist

Cytel data scientists apply advanced statistical techniques including predictive modeling of biological processes and...

Read article

September 20, 2018

Career Perspectives: Interview with Adam Hamm, Director of Biostatistics

At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...

Read article

August 23, 2018

Career Perspectives: Interview with Meredith Alm, Manager, QA Compliance

Cytel has grown significantly over the last 30 years, with operations across North America, Europe, and India. All of...

Read article

August 21, 2018

How Does a CRO Programming Career Stack Up?

After having spent 15 years in the pharmaceutical industry, in May of 2018, I decided to explore new horizons and took...

Read article

July 24, 2018

Career Perspectives: Interview with Sam Hsiao, Associate Director, Strategic Consulting

At Cytel our strategic consulting team works on a wide range of projects including: Identifying the best clinical trial...

Read article

March 16, 2018

Career Perspectives: Interview with Benjamin Esterni, Principal Biostatistician

At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...

Read article

February 28, 2018

Insight into the Coordination of Rare Diseases at Sanford registry

There is a consensus in the industry that data on rare diseases is limited, incomplete, and difficult to find or...

Read article

February 13, 2018

Career Perspectives: Interview with Ursula Garczarek, Associate Director - Strategic Consulting

Our strategic consulting team work on projects such as: Identifying the best clinical trial design, implementing...

Read article

January 9, 2018

Career Perspectives: Interview with Lisa Goldberg, Associate Director of Statistical Programming

Our Career Perspectives' series is back! Cytel has industry-leading experts in statistical programming with years of...

Read article

November 22, 2017

Career Perspectives: Interview with Makarand Deshmukh, Senior Clinical Data Analyst

Cytel offers a full range of clinical data management services and the team of experts is spread across the globe. In...

Read article